China trims Covid quarantine time by two days

China’s Covid outbreak is at its worst in about half a year. Residents of Hohhot, Inner Mongolia, are pictured here lining up for regular virus testing in their community on Nov. 10, 2022.

Future Publishing | Future Publishing | Getty Images

BEIJING — China reduced the quarantine time for international travelers by two days, state media said Friday.

Instead of having to stay at a centralized quarantine facility for seven days, the new rules stipulate a five day quarantine, followed by three days of home observation, according to state media.

related investing news

Goldman Sachs says buy these stocks ahead of a $2.6 trillion China reopening boom

The new timeframe also applied to close contacts of Covid infections within China, the report said.

This is a breaking news story. Please check back for updates.

Source

Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

December 11, 2025

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Eli Lilly to build billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

Health

Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

December 9, 2025

Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Tuesday said it will spend […]

Health

A biotech stock for investors scared to invest in the risky industry

December 9, 2025

Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand’s Monday closing price of $184.67. Shares have soared nearly 79% this year. LGND YTD mountain LGND YTD chart […]